About the CAR T Companion Tool

The CAR T Companion Tool is a free educational resource for people living with relapsed or refractory non-Hodgkin lymphoma, the caregivers who support them, and the clinicians who treat and refer them. CAR T-cell therapy is a complex form of immunotherapy in which a patient's own T cells are collected, re-engineered in a laboratory to recognize a cancer target such as CD19, and infused back into the body to seek out and destroy lymphoma cells. Because the process spans multiple appointments, several care teams, and weeks of close monitoring, families are often handed a great deal of information at once. This tool exists to organize that information into something that can be read calmly at home and revisited before every appointment.

Inside, you'll find a Patient FAQ that answers the questions people most often ask about diagnosis, testing, treatment sequencing, side effects such as cytokine release syndrome and neurologic toxicity, and recovery expectations. You'll also find a fillable digital wallet card, where a patient can record their treating oncologist, hospital, therapy name, batch or lot number, infusion date, and emergency contacts, then print the card, save it as a PDF, or share it with a local physician. For healthcare professionals, the Clinician Guide summarizes the FDA-approved CAR T-cell therapies for non-Hodgkin lymphoma, referral contacts, and eligibility considerations, with each data point linked to its original source.

The tool is developed and maintained by Integritas Communications, a medical education company that works with clinical experts to translate specialist knowledge into materials patients and community providers can actually use. Content is reviewed against current published guidance and updated as approvals and recommendations change. Everything here is educational only: it does not determine patient eligibility, provide a diagnosis, or replace a consultation with an authorized CAR T treatment center.